VarCov Co’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
VarCov Co's ADPT Position: Q3 2026 in Review
VarCov Co reduced its Adaptive Biotechnologies (ADPT) stake by 5.1% in Q3 2026, selling an estimated $25.7K and leaving 19,329 shares worth $559K. The position accounts for 0.27% of the portfolio, ranked #131.
VarCov Co first reported a position in ADPT in Q2 2026 and has held it in 2 quarters since. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- VarCov Co held 19,329 shares of Adaptive Biotechnologies worth $559K as of Q3 2026.
- VarCov Co sold 1,045 Adaptive Biotechnologies shares in Q3 2026, an estimated $25.7K.
- Adaptive Biotechnologies made up 0.27% of VarCov Co's portfolio in Q3 2026, its #131 holding.
- VarCov Co first reported a position in Adaptive Biotechnologies in Q2 2026 and has held it in 2 quarters since.
- 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.